Given AH 7614, an GPR120 antagonist, blocked the antioxidation and reversed the increased Cx43 levels of IPE, the possibility of Resolvin E1 in attenuated arrhythmias is unlikely. The gene discussed is GJA1; the disease is Arrhythmia.